Evidence map›Paper›PMID 34270590›Full record

ArticlePloS one2021

Optimal cut-off value for detecting colorectal cancer with fecal immunochemical tests according to age and sex.

Mercedes Vanaclocha-Espi, Josefa Ibáñez, Ana Molina-Barceló, María José Valverde-Roig, Andreu Nolasco, Francisco Pérez-Riquelme, Mariola de la Vega, Isabel Portillo, Dolores Salas

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Mercedes Vanaclocha-EspiFoundation for the Promotion of Health and Biomedical Research-Public Health Research FISABIO-Public Health Research, Valencia, Spain.ORCID 0000-0002-7202-2861
Josefa IbáñezFoundation for the Promotion of Health and Biomedical Research-Public Health Research FISABIO-Public Health Research, Valencia, Spain.
Ana Molina-BarcelóFoundation for the Promotion of Health and Biomedical Research-Public Health Research FISABIO-Public Health Research, Valencia, Spain.
María José Valverde-RoigGeneral Directorate Public Health, Valencian Community, Spain.
Andreu NolascoUniversity of Alicante, Alicante, Spain.ORCID 0000-0001-6583-379X
Francisco Pérez-RiquelmeGeneral Directorate of Public Health, Murcia Region, Spain.
Mariola de la VegaGeneral Directorate of Assistance Programs, Canary Islands, Spain.
Isabel PortilloThe Basque Health Service, Basque Country, Spain.
Dolores SalasFoundation for the Promotion of Health and Biomedical Research-Public Health Research FISABIO-Public Health Research, Valencia, Spain.
Generalitat Valenciana · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESInstituto Murciano de Investigación Biosanitaria · ESUniversity of Alicante · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the fecal immunological test, a suitable cut-off value may be selected to classify results as either positive or negative. Our aim is to estimate the optimal cut-off value for detecting colorectal cancer in different age and sex groups. This is a multicentric retrospective cohort study of participants in CRC screening programs with FIT between 2006 and 2012. A total of 545,505 participations were analyzed. Cancers diagnosed outside of the program were identified after a negative test result (IC_test) up until 2014. The Wilcoxon test was used to compare fecal hemoglobin levels. ROC curves were used to identify the optimal cut-off value for each age and sex group. Screening program results were estimated for different cut-off values. The results show that the Hb concentration was higher in colorectal cancer (average = 179.6μg/g) vs. false positives (average = 55.2μg/g), in IC_test (average = 3.1μg/g) vs. true negatives (average = 0μg/g), and in men (average = 166.2μg/g) vs. women (average = 140.2μg/g) with colorectal cancer. The optimal cut-off values for women were 18.3μg/g (50-59y) and 14.6μg/g (60-69y), and 16.8μg/g (50-59y) and 19.9μg/g (60-69y) for men. Using different cut-off values for each age and sex group lead to a decrease in the IC_test rate compared to the 20μg/g cut-off value (from 0.40‰ to 0.37‰) and an increase in the false positive rate (from 6.45% to 6.99%). Moreover, test sensitivity improved (90.7%), especially in men and women aged 50-59y (89.4%; 90%) and women aged 60-69y (90.2%). In conclusion, the optimal cut-off value varies for different sex and age groups and the use of an optimal cut-off value for each group improves sensitivity and leads to a small decrease in IC_tests, but also to a larger increase in false positives.

Indexed as

AgedAge FactorsColorectal NeoplasmsFalse Positive ReactionsFemaleHemoglobinsHumansImmunologic TestsMaleMiddle AgedOccult BloodReference ValuesSex FactorsHemoglobins

Identifiers

PMID34270590
PMCPMC8284629
OpenAlexW3181100544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.